Status and phase
Conditions
Treatments
About
This is an imaging study of patients with mild Alzheimer's disease receiving amyloid-targeting therapy and under the care of neurologists at Mayo Clinic in Rochester, MN.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria
Exclusion Criteria
Primary purpose
Allocation
Interventional model
Masking
135 participants in 2 patient groups
Loading...
Central trial contact
Petrice Cogswell, M.D., Ph.D.; Casey McAdam
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal